The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the genesis was a guy named jim simpkins he's a pharmacologist he's always interested in estrogen receptors and he tried to make a compound that was like estrogen that is 17 beta estradiol generically crudely referred to as estrogen 17 beta estradiol but which had much lower affinity for the classical receptors for the estrogens er alpha and beta
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.